NuCana
Utility Patents
Last updated:
List of all NuCana patents 16 in total
| Status | Patent |
|---|---|
Grant | Utility: Floxuridine synthesis Filling date: 7 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Synthesis of phosphate derivatives Filling date: 7 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Cancer treatments Filling date: 7 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Crystalline form of gemcitabine Filling date: 7 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds Filling date: 7 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Formulation comprising a gemcitabine-prodrug Filling date: 7 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Process for preparing nucleoside prodrugs Filling date: 7 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Filling date: 7 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Phosphoramidate nucleoside derivatives as anticancer agents Filling date: 7 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Formulation comprising a gemcitabine-prodrug Filling date: 7 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Diastereoselective synthesis of phosphate derivatives Filling date: 7 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Methods of separating gemcitabine-phosphate diastereoisomers Filling date: 7 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Combination therapy for cancer Filling date: 7 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Gemcitabine prodrugs Filling date: 7 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti- cancer compounds Filling date: 7 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Phosphoramidate compounds and methods of use Filling date: 7 Sep 2025 Issue date: 3 Sep 2019 |
Showing 1 to 16 of 16 patents.